Researchers need help from people with Ataxia to look for a cure and develop new treatments. Here are things that you can do to be a part of the fight against Ataxia.
Patient Registries are essential tools for Ataxia researchers. The purpose of a patient registry is to advance the development of treatments for a disease by connecting researchers with those who are affected with that disease. If you or a family member are affected by Ataxia or are at risk for Ataxia, we recommend that you sign up on the appropriate patient registry listed below (you can be included on more than one patient registry.)
The CoRDS Registry was established to facilitate the establishment of rare disease registries for all rare diseases with a specific questionnaire for those with any type of ataxia or those at risk for Ataxia.
Participating in a clinical trial is one way to take an active role in furthering understanding and treatment of Ataxia. It is also a way to get access to new treatment options before they are widely available. However, participating in a clinical trial is a deeply personal choice to make. Look into risks and benefits of each trial before enrolling. The following links are great resources for finding research studies that are looking for volunteer participants.
The following links will provide information about participating in a clinical trial.
During the COVID-19 pandemic, some in-person research studies are not being scheduled at this time. However, some studies are currently recruiting research participants for their studies and scheduling future appointments. Safety of research participants is of the utmost importance and appropriate guidelines are being followed. Please contact the institute listed for more details. Thank you.
The National Ataxia Foundation is committed to providing information to those affected by Ataxia including the availability of research studies and clinical trials for the study of Ataxia.
Below you will find clinical trials and research opportunities for those with various types of Ataxia. These trials have been approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits.
DRPLA Patients and Families Needed for Important Research Study
20 DRPLA patients and families in the UK/Europe are needed to work with Ataxia UK and CureDRPLA to develop DRPLA blood-based biomarkers of disease progression. If you are a DRPLA family who may be interested in being part of this IRB approved study, or a physician who sees patients with DRPLA, please email:
Dr. Henry Houlden
Professor of Neurology and Neurogenetics,
UCL Institute of Neurology and
The National Hospital for Neurology and Neurosurgery,
Queen Square, London WC1N 3BG.
One of the challenges in developing a treatment for a rare disease, such as Ataxia, is the lack of natural history studies. A natural history study collects data that shows how a specific disease progresses in individuals over time. Natural history studies are essential for developing clinical trial designs that will facilitate drug development. With the recent funding by the National Ataxia Foundation of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA), a natural history study will begin for SCAs 1, 2, 3, 6 and 7 (and SCA 8 and 10 at some sites). Learn how to join at our CRC-SCA page.
Donating tissue for medical research is an important and deeply personal decision. Proper planning can help ensure that wishes are accounted for and honored at the time of your or a loved one’s passing. Start your planning with the documents listed below. For additional information on tissue donation contact the National Ataxia Foundation at email@example.com or call 763-553-0020. If death is imminent or has occurred, rapid recovery is essential. Call 1-877-GoAtaxia (1-877-462-8294) as soon as death appears imminent or has occurred. Thank you for considering this important legacy gift.
Donation match provided by Priority Courier Experts and the Cossack Foundation
Every $1 you donate to the 2022 Research Drive will be matched with a $2 donation!